Saturday 17 October 2026 Export FDMT’s income statement to Excel — free account

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 230,194.6% from fiscal 2024. In the quarter to June 2026, revenue grew 25,106.7%, EPS fell 6.12% and free cash flow fell 61.3%, each against the same quarter a year earlier.

12.14 0.73 −5.67%

Follow FDMT

Alert me

Market cap: $711.0M
P/E: 0.0×
Fwd P/E: −2.2×
Dividend yield: —
F-score: 4/9
Altman Z: 2.50
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	2	3	4	3	+8 more TTM periods Free account
ROE Full definition →	(43.25%)	(34.92%)	(27.57%)	(45.38%)
ROA Full definition →	(37.09%)	(31.28%)	(24.86%)	(40.70%)
ROIC Full definition →	(186.91%)	(184.13%)	(96.80%)	(225.26%)
Return on Tangible Assets Full definition →	(51.54%)	(42.84%)	(36.49%)	(71.78%)
Average Days of Receivables Full definition →	18.29	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(2.22)	(1.90)	(1.89)	(3.30)
Free Cash Flow Full definition →	(155.96)	(129.34)	(109.62)	(185.05)
Capital Expenditures Full definition →	0.11	0.11	(0.54)	(1.55)
Other line items
Cash ROIC Full definition →	(19.78%)	(15.35%)	(12.07%)	(27.45%)
Accounts Receivable Turnover Full definition →	31.57	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	261.18%	249.29%	229.67%	150,977.50%
Selling, General and Administrative Expense of Revenue Full definition →	53.06%	54.18%	57.58%	41,105.00%
Share Based Compensation of Revenue Full definition →	22.18%	22.08%	25.84%	20,034.17%
Operating CF/Net income Full definition →	0.87	0.80	0.78	0.88
Depreciation/Fixed assets Full definition →	0.05	0.02	0.00	(0.05)
Capex/Depreciation Full definition →	0.18	0.34	13.40	1.80
Revenue per Share Full definition →	1.31	1.30	1.47	0.00
Operating CF per Share Full definition →	(2.22)	(1.90)	(1.88)	(3.27)
Capex per Share Full definition →	0.00	0.00	(0.01)	(0.03)
Capex to Sales Full definition →	0.00	0.00	0.01	12.96

Show all line items

Columns are period end dates

Stockrow Weekly